Poland· PL-100501704
Jeraygo
A aprocitentan product containing aprocitentanum, registered in Poland by Idorsia Pharmaceuticals Deutschland GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Aprocitentan is registered in 10 of 19 countries.
Countries holding a registration under ATC C02KN01 (aprocitentan), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Aprocitentan · ATC C02KN01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Aprocitentanum
- Manufacturer
- Idorsia Pharmaceuticals Deutschland GmbH
- Country
- Poland (PL)
- ATC code
- C02KN01
- ATC class
- Aprocitentan
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aprocitentan in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJERAYGOIdorsia Pharmaceuticals Deutschland GmbH, Lörrach
- SwitzerlandJeraygo 25 mg, FilmtablettenIdorsia Pharmaceuticals Ltd
- IrelandJERAYGO 25 mg film-coated tabletsIdorsia Pharmaceuticals Deutschland GmbH
- IcelandJERAYGOIdorsia Pharmaceuticals Deutschland GmbH
- NetherlandsJERAYGO 25 mg filmomhulde tablettenIdorsia Pharmaceuticals Deutschland GmbH
- BelgiumJeraygo 25 mgIdorsia Pharmaceuticals Deutschland
- SwedenJERAYGO 25 mg Filmdragerad tablettIdorsia Pharmaceuticals Deutschland GmbH
- FinlandJERAYGOIdorsia Pharmaceuticals Deutschland GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jeraygo
- Liechtenstein · Jeraygo
- Norway · Jeraygo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3e14a0a3-e685-4606-82f2-a751cd5a1b6f GET /v1/drugs/3e14a0a3-e685-4606-82f2-a751cd5a1b6f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "25 mg",
"packaging": "Rp ¦ EU/1/24/1818/003 ¦ 157222\n30 tabl.\nRp ¦ EU/1/24/1818/004 ¦ 157223\n10 tabl. w blistrze perforowanym",
"substance": "Aprocitentanum 25 mg",
"common_name": "Aprocitentanum",
"pl_product_id": "100501704",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about aprocitentan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.